Immunocompromised patients, such as organ transplant recipients and those with HIV/AIDS, have a significantly higher risk of developing skin cancer due to reduced immune surveillance against malignant cells. Early detection and preventive measures are crucial in managing skin cancer risk in these populations, as they often present with more aggressive forms of the disease.